Innovative drug licensing-out upfront payment value
Cumulative total of upfront payments received from innovative drug out-licensing transactions during the specified period.
Unit billion USD Industry Pharmaceuticals
The chart
The figure
One published observation so far. A chart follows as soon as a second period is published.
Innovative drug licensing-out upfront payment value
China, 2025
Every record
All records
1 record · 1 region · 2025
Primary documents
Sources
1 document. Each links to the publisher's own copy.
| Document | Publisher | Published | Data points |
|---|---|---|---|
| 2025年我国批准创新药76个 对外授权超千亿美元 | MOFCOM | — | 1 |
Cite & reuse
Cite this page
Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Innovative drug licensing-out upfront payment value. Retrieved from https://statorigin.org/indicators/innovative-drug-licensing-out-upfront-payment-value